Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients
Clinical trial NCT03776695 · WITHDRAWN
Trial details
- NCT number
- NCT03776695
- Sponsor
- Tychan Pte Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2022-01-05
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.